TECHLAB announces that its products meet the updated clinical practice guidelines for Clostridium difficile from the Infectious Disease Society of America (IDSA) and the Society of Healthcare Epidemiology of America (SHEA). The new recommendations emphasize the value of immunoassay toxin testing in accurately identifying C. difficile infection (CDI) and state that multistep algorithm testing is appropriate with or without patient history on all samples due to its high positive predictive value (PPV). The guidelines specifically identify TECHLAB as having nearly identical performance to a gold standard reference method when discussing the advantageous performance of the multistep algorithm.